Related Experiment Videos
Fibrinogen, a vascular risk factor: a simple marker or a real cause of vascular lesion?
1DIFEMA, Faculté de Médecine et de Pharmacie de Rouen, Saint-Etienne du Rouvray, France.
Thrombosis Research
|August 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014-2019).
Frontiers in cardiovascular medicine·2023
Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients.
Behavioural neurology·2023
Definition of minimal disease activity in psoriasis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2020
[Prevalence of osteoarticular infections by Enterobacteria producing extended-spectrum -lactamases].
Acta ortopedica mexicana·2020
Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR).
Anaesthesia, critical care & pain medicine·2018
Redefining the therapeutic objective in psoriatic patients candidates for biological therapy.
The Journal of dermatological treatment·2017
Association of Time of Day With Functional Outcome in Intracerebral Hemorrhage.
European journal of neurology·2026
Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
A new player in hemolytic uremic syndrome: the plasma kallikrein-kinin system, a target of heme.
Kidney international·2026